Sponsor:
Alzheimer's Light LLC
Code:
NCT04114994
Conditions
Alzheimer Disease
Mild Cognitive Impairment
Vascular Dementia
Frontotemporal Dementia
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Interventions
Boston Cognitive Assessment (BoCA)
Brief summary:
Conditions
Alzheimer Disease
Mild Cognitive Impairment
Vascular Dementia
Frontotemporal Dementia
Parkinson Disease
Study ID
NCT04114994
Start date
Oct 1, 2019
Status verified date
Jul, 2024
Completion date
Oct 1, 2029
Anticipated
Primary completion date
Oct 1, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Enrollment
10000 participants
Anticipated
Arms
Alzheimer's Disease
Mild Cognitive Impairment
Frontotemporal Dementia
Vascular Dementia
Parkinson Disease
Traumatic Brain Injury (TBI)
Multiple Sclerosis
No diagnosis
Interventions
Boston Cognitive Assessment (BoCA)
Primary outcome measure
Central contacts
Locations
Andrey Vyshedskiy
Recruiting
Miami, Florida, United States, 33156
Contacts
Sponsor
Alzheimer's Light LLC
Last update posted
Aug 1, 2024
Last verified
Jul, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-22. This information was provided to ClinicalTrials.gov by Alzheimer's Light LLC on 2024-08-01.